FDA NDC Directory · JSON-LD · Markdown
NDC 68254-5002 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE
| Labeler / Manufacturer | CONCORD BIOTECH LIMITED |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA211173 |
| Dosage form / route | TABLET, DELAYED RELEASE · ORAL |
| Active ingredients | MYCOPHENOLATE SODIUM (360 mg/1) |
| Marketing started | 20191213 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).